Acadia Healthcare (NASDAQ:ACHC) Price Target Cut to $70.00 by Analysts at Mizuho

Acadia Healthcare (NASDAQ:ACHC) had its price target cut by Mizuho from $84.00 to $70.00 in a research report report published on Friday morning, Benzinga reports. They currently have a neutral rating on the stock.

A number of other research analysts have also issued reports on ACHC. Cantor Fitzgerald reissued a neutral rating and set a $90.00 target price on shares of Acadia Healthcare in a research note on Tuesday, March 5th. UBS Group upped their price target on shares of Acadia Healthcare from $88.00 to $102.00 and gave the stock a buy rating in a research note on Wednesday, February 28th. Stephens raised shares of Acadia Healthcare from an equal weight rating to an overweight rating and set a $92.00 price target for the company in a research note on Friday, January 5th. Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a sell rating to a hold rating and set a $70.00 price target for the company in a research note on Thursday, April 25th. Finally, Royal Bank of Canada reiterated an outperform rating and issued a $94.00 target price on shares of Acadia Healthcare in a report on Monday, March 4th. One research analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the company. According to MarketBeat, Acadia Healthcare currently has an average rating of Moderate Buy and a consensus target price of $89.50.

Acadia Healthcare Stock Performance

Shares of NASDAQ ACHC traded down $0.61 during midday trading on Friday, hitting $66.12. The company’s stock had a trading volume of 1,213,590 shares, compared to its average volume of 674,056. Acadia Healthcare has a 1-year low of $64.74 and a 1-year high of $87.77. The firm’s fifty day moving average price is $76.77 and its 200-day moving average price is $77.52. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.67 and a current ratio of 1.27. The firm has a market cap of $6.11 billion, a P/E ratio of -472.25, a P/E/G ratio of 1.97 and a beta of 1.31.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Wednesday, May 1st. The company reported $0.84 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.80 by $0.04. The firm had revenue of $768.10 million during the quarter, compared to analyst estimates of $779.20 million. Acadia Healthcare had a negative net margin of 0.38% and a positive return on equity of 11.49%. Acadia Healthcare’s revenue was up 9.1% on a year-over-year basis. During the same period in the previous year, the business posted $0.75 EPS. On average, sell-side analysts forecast that Acadia Healthcare will post 3.56 EPS for the current fiscal year.

Insider Buying and Selling at Acadia Healthcare

In other Acadia Healthcare news, Director Wade D. Miquelon sold 2,203 shares of the business’s stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total value of $188,114.17. Following the completion of the sale, the director now directly owns 46,074 shares of the company’s stock, valued at $3,934,258.86. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 2.00% of the company’s stock.

Hedge Funds Weigh In On Acadia Healthcare

Large investors have recently bought and sold shares of the stock. Headlands Technologies LLC acquired a new position in shares of Acadia Healthcare in the 3rd quarter valued at $25,000. GAMMA Investing LLC acquired a new stake in shares of Acadia Healthcare during the 4th quarter worth approximately $26,000. Mather Group LLC. acquired a new stake in shares of Acadia Healthcare during the 1st quarter worth approximately $48,000. Fifth Third Bancorp grew its holdings in Acadia Healthcare by 25.5% during the fourth quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock valued at $52,000 after purchasing an additional 136 shares during the period. Finally, DekaBank Deutsche Girozentrale acquired a new position in Acadia Healthcare during the third quarter valued at approximately $96,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.